European Pharmaceutical Review

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗼𝘂𝗿 𝗹𝗶𝘃𝗲 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝟯𝟬 𝗝𝘂𝗹𝘆 𝗮𝘁 𝟯:𝟬𝟬 𝗣𝗠 (𝗕𝗦𝗧) to discover how advances in Process Analytical Technology (PAT), continuous manufacturing, and digital innovation are helping biopharmaceutical manufacturers optimise downstream processing. Gain practical insights from industry experts on improving efficiency, maintaining product quality, navigating regulatory expectations, and preparing for the future of biologics production in 2026 and beyond. Click "Register" now to secure your place before it's too late!

𝗝𝗼𝗶𝗻 𝘂𝘀 𝗼𝗻 𝟯𝟬 𝗝𝘂𝗹𝘆 𝗮𝘁 𝟯:𝟬𝟬 𝗣𝗠 (𝗕𝗦𝗧) 𝗳𝗼𝗿 𝗮𝗻 𝗲𝘅𝗰𝗹𝘂𝘀𝗶𝘃𝗲 𝗹𝗶𝘃𝗲 𝘄𝗲𝗯𝗶𝗻𝗮𝗿. Explore how biopharmaceutical manufacturers are advancing downstream processing by harnessing Process Analytical Technology (PAT), continuous manufacturing, and digital technologies to enhance operational efficiency, strengthen product quality, and support regulatory compliance. Hear from industry experts as they discuss the latest trends, real-world applications, and the innovations expected to shape biologics manufacturing in 2026 and beyond. Secure your free place today by clicking "Join" below!

𝗦𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝗽𝗹𝗮𝗰𝗲 𝗳𝗼𝗿 𝗼𝘂𝗿 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝟯𝟬 𝗝𝘂𝗹𝘆 𝗮𝘁 𝟯:𝟬𝟬 𝗣𝗠 (𝗕𝗦𝗧). Discover how leading biopharmaceutical manufacturers are transforming downstream processing through Process Analytical Technology (PAT), continuous manufacturing, and digital innovation to improve efficiency, product quality, and regulatory compliance. Join industry experts as they share practical insights into the future of biologics production and the innovations shaping manufacturing in 2026 and beyond. Register "Attend" to secure your place at this upcoming webinar.

If your work involves formulation, analytical science, process development or pharmaceutical R&D, this webinar will provide practical insight into how crystal solid form optimisation can help reduce formulation risk, improve manufacturability and strengthen development confidence earlier in the lifecycle. Interested? Reserve your place now to hear expert insight into crystal solid form optimisation strategies!

Many pharmaceutical development delays can be traced back to early-stage solid-form decisions. Understanding how crystal properties influence manufacturability, formulation robustness and long-term stability is becoming increasingly important across pharmaceutical R&D, process development and CMC functions. This webinar will explore practical strategies for: ✅ Evaluating crystal form risk ✅ Improving development confidence ✅ Supporting scale-up readiness ✅ Reducing avoidable technical setbacks Designed for formulation scientists, pharmaceutical development teams and technical leaders working across drug product development. Register now to secure your place!

Polymorphism, crystallisation behaviour and phase stability continue to present significant challenges in pharmaceutical development. Solid-state properties can directly influence solubility, bioavailability, stability and downstream manufacturability, making crystal form optimisation an increasingly important consideration for development teams working under compressed timelines. This webinar explores practical approaches to crystal solid form optimisation and how a stronger understanding of solid-state behaviour can support more robust formulation, analytical and process development strategies. Don’t miss this opportunity to hear practical perspectives on one of the most important challenges in pharmaceutical development - register now!